Clinical Trial Update: Study on Allopregnanolone and Depression in Women Across the Menopause Transition [NA]

View source ↗

Summary

Clinical trial evaluating allopregnanolone for depression in women across the menopause transition is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Depression | NA | Status: RECRUITING